Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neoantigen-Specific Immune Response
- Molecular classification
- Immune response, Adaptive immunity
01
Overview
A neoantigen-specific immune response is an adaptive reaction primarily mediated by cytotoxic T-cells recognizing mutation-derived peptides exclusively presented on cancerous tissue. This mechanism underpins several promising personalized immunotherapy strategies due its high specificity and strong immunogenic potential without significant risk for autoimmunity or damage to healthy tissues.
- Other names
- Tumor-specific T cell responseNeoantigen-directed immunityMutation-associated neoantigen response
02
Mechanism of action
T cell recognition of neoantigen-HLA complexes leading to T cell activation, proliferation, and killing of tumor cells.
03
Biological functions
Anti-tumor immunityT cell activationCytokine productionTargeted cell death
04
Disease associations
CancerImmune evasion
05
Safety considerations
Cytokine release syndrome (CRS)On-target, off-tumor toxicity (rare)Autoimmunity (rare)Injection site reactions (vaccines)
06
Interacting drugs
Checkpoint inhibitors (e.g., anti-PD1, anti-PD-L1, anti-CTLA4 antibodies)
2 more in the full profile.
07
Biomarkers
Neoantigen burdenTumor Mutational Burden (TMB)HLA typeT cell receptor (TCR) repertoireNeoantigen-specific T cell frequencyExpression of immune checkpoint proteins (PD-1, CTLA-4)
Beyond the preview
Go deeper on Neoantigen-Specific Immune Response.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neoantigen-Specific Immune Response.